July 29, 2009 – The Society of Nuclear Medicine (SNM) and a coalition of eight other organizations have issued a white paper urging Congress to take steps to maintain adequate supplies of molybdenum-99 (Mo-99), a radioactive substance that is the basis for a common medical isotope used in more than 80 percent of all nuclear medicine procedures.

July 28, 2009 – Sanofi-aventis said today MULTAQ (dronedarone) 400 mg tablets are now available in pharmacies in the United States.

July 28, 2009 – The American College of Cardiology (ACC) is taking a leading role in healthcare reform in partnership with patients, lawmakers and payers. The ACC said it is setting a new standard for healthcare delivery, one that centers on increasing the quality of care and ensuring greater patient access and value.

July 27, 2009 - TeraRecon Inc., a leader in advanced visualization and decision support solutions for medical imaging and a partner of the Society of Cardiovascular Computed Tomography (SCCT), and Agfa HealthCare released the first cardiac CT review and reporting solution which conforms to the SCCT’s published guidelines* for cardiac CT interpretation.

July 27, 2009 – Terumo Cardiovascular Systems said Friday it initiated a phase II clinical trial for the Anaconda AAA (abdominal aortic aneurysm) stent graft system in the U.S.

July 24, 2009 – Michael Jones has become the world’s first recipient of adult cardiac stem cells to treat congestive heart failure. Jones’ infusion on July 17 marks the world’s first phase-one, FDA-approved clinical trial using c-kit-positive cardiac stem cells to treat heart disease being conducted by a team of University of Louisville physicians at Jewish Hospital.

July 24, 2009 – The 30-day survival improved in patients with acute myocardial infarction complicated by cardiogenic shock who were treated with intra-aortic balloon pump (IABP) counterpulsation, according to a new study in the American Journal of Cardiology (vol. 104, issue 3, pages 327-332, August 2009).

July 23, 2009 – The FDA’s Circulatory System Devices Panel today recommended (12-0) conditional approval of a humanitarian device exemption (HDE) for Medtronic’s Melody Transcatheter Pulmonary Valve, for the treatment of children and adults with congenital heart disease.